WASHINGTON, D.C. and ATLANTA -- As of July 3 2003, the Centers for Disease Control and Prevention (CDC) removed its travel alert for mainland China, with the exception of Beijing, to reflect the changing status of Severe Acute Respiratory Syndrome (SARS) cases reported in this area. The alert for mainland China was lifted because more than 30 days had elapsed since the date of onset of symptoms for the last SARS case.
The travel alert for Beijing remains in effect until there is no evidence of new cases for three maximal incubation periods after the date of onset of symptoms for the last case. For SARS, this period would be 30 days.
In response to the SARS epidemic, CDC issues two types of notices to travelers: alerts and advisories. A travel advisory recommends that nonessential travel be deferred; a travel alert does not advise against travel, but informs travelers of a health concern and provides advice about specific precautions. Recommendations to postpone travel or observe precautions are issued in consideration of several factors, including the magnitude of current SARS cases, the pattern of recent local transmission, and the last date of onset of cases.
Beijing, Hong Kong, Taiwan and Toronto are the remaining areas under CDC's travel alert. CDC continues to distribute health alert notices about SARS to people traveling to the United States from these areas. Individuals who travel to Beijing, Hong Kong, Taiwan, and Toronto should monitor their health while there and for at least 10 days after departure. If fever or respiratory symptoms (for example, cough or shortness of breath) develop, a visit to a healthcare provider is strongly recommended. The provider should be informed about the symptoms in advance so arrangements can be made, if necessary, to prevent transmission to others in the healthcare setting
Source: CDC
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.
From Shortages to Security: How Reusable Health Care Textiles Can Transform Infection Prevention
March 7th 2025Reusable health care textiles enhance infection prevention, reduce waste, and strengthen supply chains. Hygienically clean textiles offer a sustainable, cost-effective alternative to disposable PPE, ensuring patient safety and environmental responsibility.